In clinical contexts, CD25 is used as one of the minor diagnostic markers to discriminate neoplastic mast cells from normal/reactive mast cells in indolent mast cell disease, and CD25 expression indicates histologically occult bone marrow infiltration and residual disease after therapy (47, 48). The gene discussed is IL2RA; the disease is maculopapular cutaneous mastocytosis.